Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News must be good.....................

<< Previous

Bullboard Posts

Next >>

Comment by iknowsmthingon Dec 02, 2021 3:34pm

484 Views

Post# 34191775

RE:RE:RE:News must be good.....................

Theralase has usually been very quite on Twitter. Looks like that is changing as well, should draw more attention and more buyers, as you say.

Theralase Technologies (TSXV: TLT) (@TheralaseTech) Tweeted:
We are pleased to release the Company Newsletter for the third quarter of 2021. The Newsletter provides updates on the previous quarter and the progress on the Phase II Non-Muscle Invasive Bladder Cancer Clinical Study.

Read the full newsletter: https://t.co/5owVoUYeKM https://t.co/Y7MFzTx5ju
https://twitter.com/TheralaseTech/status/1465470640182505474?s=20

menoalittle wrote: new 52 week high is being teed up.

which, that alone will draw more attention (and, more buyers... especially after the weekend, when they've actually had more time to better digest - and perhaps better comprehend - recent news.)